Swiss National Bank Gossamer Bio, Inc. Transaction History

Swiss National Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$1.74 - $12.87 $4,350 - $32,174	2,500 Added 2.04%	124,800 $270,000
Q3 2022 Nov 09, 2022	BUY	$7.21 - $14.88 $102,382 - $211,296	14,200 Added 13.14%	122,300 $1.47 Million
Q2 2022 Aug 09, 2022	SELL	$5.97 - $9.97 $56,118 - $93,718	-9,400 Reduced 8.0%	108,100 $905,000
Q1 2022 May 09, 2022	BUY	$8.44 - $12.49 $73,428 - $108,663	8,700 Added 8.0%	117,500 $1.02 Million
Q2 2021 Aug 06, 2021	SELL	$8.0 - $9.75 $20,800 - $25,350	-2,600 Reduced 2.33%	108,800 $883,000
Q4 2020 Feb 05, 2021	SELL	$8.3 - $13.59 $68,890 - $112,797	-8,300 Reduced 6.93%	111,400 $1.08 Million
Q3 2020 Nov 09, 2020	BUY	$11.3 - $14.75 $20,340 - $26,550	1,800 Added 1.53%	119,700 $1.49 Million
Q2 2020 Aug 05, 2020	BUY	$9.52 - $15.98 $761,600 - $1.28 Million	80,000 Added 211.08%	117,900 $1.53 Million
Q4 2019 Feb 06, 2020	BUY	$14.82 - $26.79 $16,302 - $29,469	1,100 Added 2.99%	37,900 $592,000
Q2 2019 Aug 02, 2019	BUY	$16.12 - $22.89 $593,216 - $842,352	36,800 New	36,800 $816,000

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.